BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 15542527)

  • 1. Influence of biliary cirrhosis on the detoxification and elimination of a food derived carcinogen.
    Dietrich CG; Geier A; Wasmuth HE; Matern S; Gartung C; de Waart DR; Elferink RP
    Gut; 2004 Dec; 53(12):1850-5. PubMed ID: 15542527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bcrp1;Mdr1a/b;Mrp2 combination knockout mice: altered disposition of the dietary carcinogen PhIP (2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine) and its genotoxic metabolites.
    Vlaming ML; Teunissen SF; van de Steeg E; van Esch A; Wagenaar E; Brunsveld L; de Greef TF; Rosing H; Schellens JH; Beijnen JH; Schinkel AH
    Mol Pharmacol; 2014 Mar; 85(3):520-30. PubMed ID: 24334255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The breast cancer resistance protein (Bcrp1/Abcg2) restricts exposure to the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
    van Herwaarden AE; Jonker JW; Wagenaar E; Brinkhuis RF; Schellens JH; Beijnen JH; Schinkel AH
    Cancer Res; 2003 Oct; 63(19):6447-52. PubMed ID: 14559835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consequences of bile duct obstruction on intestinal expression and function of multidrug resistance-associated protein 2.
    Dietrich CG; Geier A; Salein N; Lammert F; Roeb E; Oude Elferink RP; Matern S; Gartung C
    Gastroenterology; 2004 Apr; 126(4):1044-53. PubMed ID: 15057744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of UGT1 isoforms in Gunn rats changes metabolic ratio and facilitates excretion of the food-derived carcinogen 2-amino-1-methyl-6-phenylimidazo.
    Dietrich CG; Ottenhoff R; de Waart DR; Oude-Elferink RP
    Toxicol Appl Pharmacol; 2001 Jan; 170(2):137-43. PubMed ID: 11162778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The colon carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) is actively secreted in the distal colon of the rat: an integrated view on the role of PhIP transport and metabolism in PhIP-induced colon carcinogenesis.
    Nicken P; Schröder B; von Keutz A; Breves G; Steinberg P
    Arch Toxicol; 2013 May; 87(5):895-904. PubMed ID: 23306951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mrp2-deficiency in the rat impairs biliary and intestinal excretion and influences metabolism and disposition of the food-derived carcinogen 2-amino-1-methyl-6-phenylimidazo.
    Dietrich CG; de Waart DR; Ottenhoff R; Bootsma AH; van Gennip AH; Elferink RP
    Carcinogenesis; 2001 May; 22(5):805-11. PubMed ID: 11323401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple mechanisms are involved in the biliary excretion of acetaminophen sulfate in the rat: role of Mrp2 and Bcrp1.
    Zamek-Gliszczynski MJ; Hoffmaster KA; Tian X; Zhao R; Polli JW; Humphreys JE; Webster LO; Bridges AS; Kalvass JC; Brouwer KL
    Drug Metab Dispos; 2005 Aug; 33(8):1158-65. PubMed ID: 15860656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased bioavailability of the food-derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in MRP2-deficient rats.
    Dietrich CG; de Waart DR; Ottenhoff R; Schoots IG; Elferink RP
    Mol Pharmacol; 2001 May; 59(5):974-80. PubMed ID: 11306678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of breast cancer resistance protein in colon adenomas reduces cellular xenobiotic resistance and leads to accumulation of a food-derived carcinogen.
    Dietrich CG; Vehr AK; Martin IV; Gassler N; Rath T; Roeb E; Schmitt J; Trautwein C; Geier A
    Int J Cancer; 2011 Aug; 129(3):546-52. PubMed ID: 21544799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of glucuronidation on the bioactivation and DNA adduction of the cooked-food carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in vivo.
    Malfatti MA; Ubick EA; Felton JS
    Carcinogenesis; 2005 Nov; 26(11):2019-28. PubMed ID: 15944213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial effect of spironolactone administration on ethynylestradiol-induced cholestasis in the rat: involvement of up-regulation of multidrug resistance-associated protein 2.
    Ruiz ML; Villanueva SS; Luquita MG; Ikushiro S; Mottino AD; Catania VA
    Drug Metab Dispos; 2007 Nov; 35(11):2060-6. PubMed ID: 17686906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myricetin stimulates the absorption of the pro-carcinogen PhIP.
    Schutte ME; van de Sandt JJ; Alink GM; Groten JP; Rietjens IM
    Cancer Lett; 2006 Jan; 231(1):36-42. PubMed ID: 16356829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biotransformation and transport of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in bile duct-cannulated wild-type and Mrp2/Abcc2-deficient (TR ) Wistar rats.
    Leslie EM; Ghibellini G; Nezasa K; Brouwer KL
    Carcinogenesis; 2007 Dec; 28(12):2650-6. PubMed ID: 17724374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of transporters in the disposition of the selective phosphodiesterase-4 inhibitor (+)-2-[4-({[2-(benzo[1,3]dioxol-5-yloxy)-pyridine-3-carbonyl]-amino}-methyl)-3-fluoro-phenoxy]-propionic acid in rat and human.
    Kalgutkar AS; Feng B; Nguyen HT; Frederick KS; Campbell SD; Hatch HL; Bi YA; Kazolias DC; Davidson RE; Mireles RJ; Duignan DB; Choo EF; Zhao SX
    Drug Metab Dispos; 2007 Nov; 35(11):2111-8. PubMed ID: 17686907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of P-glycoprotein, Bcrp, and Mrp2 in biliary excretion of spiramycin in mice.
    Tian X; Li J; Zamek-Gliszczynski MJ; Bridges AS; Zhang P; Patel NJ; Raub TJ; Pollack GM; Brouwer KL
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3230-4. PubMed ID: 17576841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple human isoforms of drug transporters contribute to the hepatic and renal transport of olmesartan, a selective antagonist of the angiotensin II AT1-receptor.
    Yamada A; Maeda K; Kamiyama E; Sugiyama D; Kondo T; Shiroyanagi Y; Nakazawa H; Okano T; Adachi M; Schuetz JD; Adachi Y; Hu Z; Kusuhara H; Sugiyama Y
    Drug Metab Dispos; 2007 Dec; 35(12):2166-76. PubMed ID: 17823233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ticlopidine, a cholestatic liver injury-inducible drug, causes dysfunction of bile formation via diminished biliary secretion of phospholipids: involvement of biliary-excreted glutathione-conjugated ticlopidine metabolites.
    Yoshikado T; Takada T; Yamamoto H; Tan JK; Ito K; Santa T; Suzuki H
    Mol Pharmacol; 2013 Feb; 83(2):552-62. PubMed ID: 23220748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alteration of the expression of adenosine triphosphate-binding cassette transporters associated with bile acid and cholesterol transport in the rat liver and intestine during cholestasis.
    Kamisako T; Ogawa H
    J Gastroenterol Hepatol; 2005 Sep; 20(9):1429-34. PubMed ID: 16105132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An in vitro and in silico study on the flavonoid-mediated modulation of the transport of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) through Caco-2 monolayers.
    Schutte ME; Freidig AP; van de Sandt JJ; Alink GM; Rietjens IM; Groten JP
    Toxicol Appl Pharmacol; 2006 Dec; 217(2):204-15. PubMed ID: 16997339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.